Connection
Katja Aviszus to Antiviral Agents
This is a "connection" page, showing publications Katja Aviszus has written about Antiviral Agents.
|
|
Connection Strength |
|
|
|
|
|
0.129 |
|
|
|
-
Liu H, Wei P, Zhang Q, Chen Z, Aviszus K, Downing W, Peterson S, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G. 501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro. MAbs. 2021 Jan-Dec; 13(1):1919285.
Score: 0.129